These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37467575)

  • 1. MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8.
    Mandato E; Yan Q; Ouyang J; Paczkowska J; Qin Y; Hao Y; Bojarczuk K; Hansen J; Chapuy B; Rodig SJ; Khan SJ; Redd RA; Shipp MA
    Blood; 2023 Oct; 142(14):1219-1232. PubMed ID: 37467575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
    Davis RE; Ngo VN; Lenz G; Tolar P; Young RM; Romesser PB; Kohlhammer H; Lamy L; Zhao H; Yang Y; Xu W; Shaffer AL; Wright G; Xiao W; Powell J; Jiang JK; Thomas CJ; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Johnson NA; Rimsza LM; Campo E; Jaffe ES; Wilson WH; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pierce SK; Staudt LM
    Nature; 2010 Jan; 463(7277):88-92. PubMed ID: 20054396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.
    Akhter A; Masir N; Elyamany G; Phang KC; Mahe E; Al-Zahrani AM; Shabani-Rad MT; Stewart DA; Mansoor A
    J Neurooncol; 2015 Jan; 121(2):289-96. PubMed ID: 25391967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14.
    Choi J; Phelan JD; Wright GW; Häupl B; Huang DW; Shaffer AL; Young RM; Wang Z; Zhao H; Yu X; Oellerich T; Staudt LM
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6092-6102. PubMed ID: 32127472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multiprotein supercomplex controlling oncogenic signalling in lymphoma.
    Phelan JD; Young RM; Webster DE; Roulland S; Wright GW; Kasbekar M; Shaffer AL; Ceribelli M; Wang JQ; Schmitz R; Nakagawa M; Bachy E; Huang DW; Ji Y; Chen L; Yang Y; Zhao H; Yu X; Xu W; Palisoc MM; Valadez RR; Davies-Hill T; Wilson WH; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Rodriguez FJ; Estephan F; Holdhoff M; Kruhlak MJ; Hewitt SM; Thomas CJ; Pittaluga S; Oellerich T; Staudt LM
    Nature; 2018 Aug; 560(7718):387-391. PubMed ID: 29925955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation.
    Jabara HH; McDonald DR; Janssen E; Massaad MJ; Ramesh N; Borzutzky A; Rauter I; Benson H; Schneider L; Baxi S; Recher M; Notarangelo LD; Wakim R; Dbaibo G; Dasouki M; Al-Herz W; Barlan I; Baris S; Kutukculer N; Ochs HD; Plebani A; Kanariou M; Lefranc G; Reisli I; Fitzgerald KA; Golenbock D; Manis J; Keles S; Ceja R; Chatila TA; Geha RS
    Nat Immunol; 2012 May; 13(6):612-20. PubMed ID: 22581261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy.
    Phelan JD; Scheich S; Choi J; Wright GW; Häupl B; Young RM; Rieke SA; Pape M; Ji Y; Urlaub H; Bolomsky A; Doebele C; Zindel A; Wotapek T; Kasbekar M; Collinge B; Huang DW; Coulibaly ZA; Morris VM; Zhuang X; Enssle JC; Yu X; Xu W; Yang Y; Zhao H; Wang Z; Tran AD; Shoemaker CJ; Shevchenko G; Hodson DJ; Shaffer AL; Staudt LM; Oellerich T
    Cancer Cell; 2024 Feb; 42(2):238-252.e9. PubMed ID: 38215749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
    Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
    Front Immunol; 2019; 10():95. PubMed ID: 30761150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma.
    Bogusz AM; Baxter RH; Currie T; Sinha P; Sohani AR; Kutok JL; Rodig SJ
    Clin Cancer Res; 2012 Nov; 18(22):6122-35. PubMed ID: 22966017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas.
    Chen L; Ouyang J; Wienand K; Bojarczuk K; Hao Y; Chapuy B; Neuberg D; Juszczynski P; Lawton LN; Rodig SJ; Monti S; Shipp MA
    Haematologica; 2020 May; 105(5):1361-1368. PubMed ID: 31471373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
    Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.
    Juszczynski P; Chen L; O'Donnell E; Polo JM; Ranuncolo SM; Dalla-Favera R; Melnick A; Shipp MA
    Blood; 2009 Dec; 114(26):5315-21. PubMed ID: 19855081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis.
    Yu X; Li W; Deng Q; Liu H; Wang X; Hu H; Cao Y; Xu-Monette ZY; Li L; Zhang M; Lu Z; Young KH; Li Y
    Blood; 2021 Mar; 137(12):1615-1627. PubMed ID: 33025009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD19 controls Toll-like receptor 9 responses in human B cells.
    Morbach H; Schickel JN; Cunningham-Rundles C; Conley ME; Reisli I; Franco JL; Meffre E
    J Allergy Clin Immunol; 2016 Mar; 137(3):889-98.e6. PubMed ID: 26478008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenically active MYD88 mutations in human lymphoma.
    Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
    Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
    Seda V; Mraz M
    Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma.
    Meriranta L; Sorri S; Huse K; Liu X; Spasevska I; Zafar S; Chowdhury I; Dufva O; Sahlberg E; Tandarić L; Karjalainen-Lindsberg ML; Hyytiäinen M; Varjosalo M; Myklebust JH; Leppä S
    Blood Cancer Discov; 2024 Sep; 5(5):331-352. PubMed ID: 38630892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma.
    Chen L; Monti S; Juszczynski P; Daley J; Chen W; Witzig TE; Habermann TM; Kutok JL; Shipp MA
    Blood; 2008 Feb; 111(4):2230-7. PubMed ID: 18006696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.
    Rip J; de Bruijn MJW; Neys SFH; Singh SP; Willar J; van Hulst JAC; Hendriks RW; Corneth OBJ
    Eur J Immunol; 2021 Sep; 51(9):2251-2265. PubMed ID: 34323286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dock8 regulates BCR signaling and activation of memory B cells via WASP and CD19.
    Sun X; Wang J; Qin T; Zhang Y; Huang L; Niu L; Bai X; Jing Y; Xuan X; Miller H; Zhao Y; Song W; Tang X; Zhang Z; Zhao X; Liu C
    Blood Adv; 2018 Feb; 2(4):401-413. PubMed ID: 29472447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.